RWD6 Costs of Dose Escalation Among Patients with Inflammatory Bowel Disease Treated with Vedolizumab and Ustekinumab in Portugal
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2724
https://www.valueinhealthjournal.com/article/S1098-3015(23)05854-0/fulltext
Title :
RWD6 Costs of Dose Escalation Among Patients with Inflammatory Bowel Disease Treated with Vedolizumab and Ustekinumab in Portugal
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05854-0&doi=10.1016/j.jval.2023.09.2724
First page :
Section Title :
Open access? :
No
Section Order :
12056